Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 7.98
+0.14 (1.79%)
At close: Sep 4, 2026
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €41.68 million as of September 4, 2026. Its market cap has decreased by -3.64% in one year.
Market Cap
41.68M
Enterprise Value
80.75M
Revenue
141.56M
Ranking
n/a
PE Ratio
6.17
Stock Price
€7.98
ChartMarket Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 41.68M, a decrease of -48.64%. That is a compound annual growth rate of -13.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 41.68M | -1.95% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.63B |
| DiaSorin | 3.73B |
| Amplifon | 3.14B |
| EL.En. | 1.22B |
| GPI S.p.A. | 393.46M |
| Talea Group | 40.74M |
| Arterra Bioscience | 20.31M |
| Helyx Industries | 19.02M |